[The tomitsid treatment of chronic cystitis in children].
The clinical efficiency of tomicid used in the treatment of childhood cystitis was examined by employing clinical, endoscopic, microbiological, and immunological findings. A total of 140 children were examined. These include 78 with chronic obstructive pyelonephritis without cystitis and 62 with chronic cystitis. The urinary bladder was instilled with reference tomicid solution in 18 children with chronic cystitis during 10-12 days. Tomicid was found to produce bactericidal and anti-inflammatory effects. The immunomodulating effect was shown mainly in young children (aged 1-6 years). The lack of toxic and adverse effects of the drug allows one to recommend for use in pediatric urologic practice.
Iatsyk
P K
PK
Sentsova
T B
TB
Aiazbekov
E A
EA
Borisov
I N
IN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D001430:Bacteriocins; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003556:Cystitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D004341:Drug Evaluation; D006801:Humans; D007223:Infant; D011704:Pyelonephritis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D001430:Bacteriocins; C026129:tomicide
Lechenie tomitsidom khronicheskogo tsistita u deteĭ.